Anzeige
Mehr »
Login
Mittwoch, 01.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Paukenschlag in USA: Cannabis-Neuregulierung durch DEA sorgt für Kursexplosion!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
50 Leser
Artikel bewerten:
(0)

Global High Throughput Screening (Label-Free Technology, Cell-Based Assay, and Others) Strategic Business Report 2015-2022 - Research and Markets

DUBLIN, Dec 9, 2016 /PRNewswire/ --

Research and Markets has announced the addition of the "High Throughput Screening (HTS) - Global Strategic Business Report" report to their offering.

The report also analyses the market by the following Technology Types: Label-Free Technology, Cell-Based Assay, and Others. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World.

Annual estimates and forecasts are provided for the period 2015 through 2022. Also, a six-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research.

This report analyzes the worldwide markets for High Throughput Screening (HTS) in US$ Million by the following Product Segments: Consumables/Reagents, Instruments, and Software and Services.

The report profiles 104 companies including many key and niche players such as

  • Agilent Technologies, Inc. (US)
  • Aurora Biomed, Inc. (Canada)
  • Axxam SpA (Italy)
  • BD Biosciences (US)
  • Danaher Corporation (US)
  • Beckman Coulter, Inc. (US)
  • Molecular Devices Inc. (US)
  • Bio-Rad Laboratories, Inc. (US)
  • BioTek Instruments Inc. (US)
  • BMG LABTECH GmbH (Germany)
  • Charles River Laboratories International, Inc. (US)
  • Corning Inc. (US)
  • DiscoveRx Corporation (US)
  • Evotec AG (Germany)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • ForteBio (US)
  • Genedata AG (Switzerland)
  • IntelliCyt® Corporation (US)
  • Luminex Corporation (US)
  • PerkinElmer, Inc. (US)
  • Sigma-Aldrich Corp. (US)
  • Tecan Group Ltd. (Switzerland)
  • Thermo Fisher Scientific Inc. (US)

Key Topics Covered:

1. Industry Overview

2. Key Market Trends & Growth Drivers

3. Product Overview

4. Drug Discovery - An Overview

5. Product Innovations/Introductions

6. Recent Industry Activity

7. Focus On Select Global Players

8. Global Market Perspective

Total Companies Profiled: 104 (including Divisions/Subsidiaries 107)

  • The United States (64)
  • Canada (2)
  • Japan (2)
  • Europe (34)
  • - France (4)
  • - Germany (7)
  • - The United Kingdom (10)
  • - Italy (1)
  • - Spain (1)
  • - Rest of Europe (11)
  • Asia-Pacific (Excluding Japan) (5)

For more information about this report visit http://www.researchandmarkets.com/research/sdmbtn/high_throughput

Media Contact:

Research and Markets

Laura Wood, Senior Manager

press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470

For U.S./CAN Toll Free Call +1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907

Fax (outside U.S.): +353-1-481-1716

Lithium vs. Palladium - Zwei Rohstoff-Chancen traden
In diesem kostenfreien PDF-Report zeigt Experte Carsten Stork interessante Hintergründe zu den beiden Rohstoffen inkl. . Zudem gibt er Ihnen konkrete Produkte zum Nachhandeln an die Hand, inkl. WKNs.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.